NCT07226804Recruiting
Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules
Source: ClinicalTrials.gov · Last updated 1 Jun 2026
Brief summary (registry, in English)
To observe the outcomes of nsPFA therapy to treat benign thyroid nodules.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 30 (estimated)
- First submitted
- 7 Nov 2025
- Start date
- 14 Nov 2025
- Primary completion date
- 31 Aug 2028
- Lead sponsor
- M.D. Anderson Cancer Center
- NCT number
- NCT07226804
What you commit to
- Study type: Observational
- Planned participants: 30
- From 14 Nov 2025 to the primary completion date, 31 Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \<18
Other
- Patients considered unsuitable for nsPFA by the treating physician
Criteria the registry did not label
- Eligibility Criteria
- Scheduled to undergo ultrasound guided nsPFA as standard of care
- Age 18 to 80 years.
- Capable of providing independent consent.
- Presence of biopsy-confirmed benign thyroid nodule , defined as one of the following:
- Benign FNA X 2 or
- Benign US guided FNA X 1 + benign thyroid nodule ultrasound appearance (TI-RADS 2) or
- Benign FNA X 1 and radiographic/laboratory evidence of functional nature
- Nodule measuring \>2cm in greatest dimension
- Presence of compressive symptoms reasonably attributable to thyroid nodule (i.e. pressure sensation, dysphagia, dysphonia, respiratory distress)
- No abnormal cervical lymph nodes during screening visit .
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MD Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.